Archive · 12 Dec 2025
Pune to Launch HPV Vaccination Program in 2026
The Pune Zilla Parishad is teaming up with the Serum Institute of India and the Jivika Foundation to start a program that will give HPV vaccines to young girls in schools.
This vaccine helps prevent cervical cancer, a serious disease.
The program will begin in January 2026 and will first focus on girls aged 9 to 14 in three areas: Baramati, Indapur, and Daund.
The girls will get two doses of the vaccine, six months apart.
The Serum Institute has promised to provide one lakh doses.
The program also aims to educate people about the importance of screening for cervical cancer and supporting those who test positive.
This effort is part of a global strategy to eliminate cervical cancer, as India has a high number of cases and deaths from this disease.
Pune Zilla Parishad collaborates with Serum Institute of India and Jivika Foundation for HPV vaccination program.
Program targets 50,000 school girls aged 9-14 in Baramati, Indapur, and Daund, starting January 2026.
Two doses of the HPV vaccine will be administered six months apart.
Serum Institute has committed one lakh doses for the program.
The initiative includes awareness campaigns and support for screening and diagnosis of cervical cancer.
- Who
- Pune Zilla Parishad, Serum Institute of India, Jivika Foundation, and rural girl children in Pune district
- What
- Launch of an HPV vaccination program to prevent cervical cancer
- When
- Beginning January 2026
- Where
- Pune district, initially focusing on Baramati, Indapur, and Daund
- Why
- To prevent cervical cancer and reduce its prevalence in the region, aligning with WHO's 90-70-90 strategy
- Organizations Involved
- Pune Zilla Parishad, Serum Institute of India, Jivika Foundation
- Target Population
- 50,000 school girls (age 9-14) in Baramati, Indapur, and Daund
- Vaccination Schedule
- Two doses, six months apart
- Vaccine Doses Committed
- One lakh doses by Serum Institute of India
- Global Cervical Cancer Statistics
- India accounts for 25% of global cervical cancer deaths